Recent Updates
Recently added Catalysts

Dermacid Silver

Phase 3

Hygiene | Small molecule | Other |Sanofi|Last Updated: Dec 2, 2010

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedCONTROLLED
Total Trials1
Total Enrollment70

FDA Designations

No designations recorded

Clinical trial landscape

Dermacid Silver · 1 trial · 1 indication

Phase 3 1
NCT01126606Comparative Safety and Efficacy Evaluation Between Dermacyd Silver and Glycerine Vegetal Soap Granado TraditionalHygiene
COMPLETED70 Analytics
PHASE3COMPLETED
Comparative Safety and Efficacy Evaluation Between Dermacyd Silver and Glycerine Vegetal Soap Granado Traditional
HygieneUnlock trial analytics

Study Endpoints

Primary Endpoints

Transepidermal water loss measurement (TEWL) and corneometry
Up to Week 9

Measures taken at all visits by Tewameter equipment TM 300. The value of the average will be considered for analysis of final results. Corneometry: Measures taken at all visits by Corneometer equipment MPA 580.

Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingNONE
ModelCROSSOVER
PurposeTREATMENT

Treatment Arms

ArmTypeDescription
Group 1EXPERIMENTALDermacyd Silver Frutal followed by Dermacyd Silver Frutal+PH\_DESYLSTY\_FR followed by wash out followed by Glycerine Vegetal Soap Granado Traditional
Group 2EXPERIMENTALGlycerine Vegetal Soap Granado Traditional followed by wash out followed by Dermacyd Silver Floral followed by Dermacyd Silver Floral + PH\_DESYLSTY\_FR

Interventions

NameTypeDescription
Dermacid Silver (Lactic acid)DRUGLiquid soap, daily use
Glycerine Vegetal Soap Granado TraditionalDRUGVegetal soap, daily use
Unlock Study Design Details

Eligibility Criteria

Age Range45 Years to 65 Years
SexFEMALE
Healthy VolunteersNo
Study Sites1

Inclusion criteria: * Active sex life * Menopause for at least 6 months * Perfect mucosa in the evaluated area * Use the same cosmetics category Exclusion criteria: * Use of antiinflammatory / immunosuppression / antihistaminic drugs * Personal history of atopy to cosmetic products * Cutaneous ac...

Countries:Brazil
Unlock Eligibility Criteria

Frequently asked questions about Dermacid Silver

What is Dermacid Silver used for?

Dermacid Silver is an investigational small molecule being developed for hygiene purposes. It is currently in Phase 3 clinical development. The drug has been studied in a completed clinical trial involving 70 participants in Brazil, focusing on hygiene-related conditions.

Who makes Dermacid Silver?

Dermacid Silver is being developed by Sanofi, a global biopharmaceutical company traded on the stock exchange under the ticker SNY. The drug is currently in Phase 3 clinical development for hygiene indications.

What phase is Dermacid Silver in?

Dermacid Silver is in Phase 3 clinical development. It is an investigational drug, meaning it has not yet been approved by regulatory authorities. The drug is being studied for hygiene purposes, with one completed Phase 3 trial.

What clinical trials is Dermacid Silver in?

Dermacid Silver has one completed clinical trial registered as NCT01126606. This Phase 3 study, titled 'Comparative Safety and Efficacy Evaluation Between Dermacyd Silver and Glycerine Vegetal Soap Granado Traditional,' enrolled 70 female participants aged 45 years and older in Brazil.

Is Dermacid Silver the same as Dermacyd Silver?

Dermacid Silver is also known as Dermacyd Silver. The clinical trial NCT01126606 uses the name Dermacyd Silver, while the drug is referred to as Dermacid Silver in development records. Both names refer to the same investigational drug.